Knowing the risk factors for HSV keratitis can reduce its occurrence

Knowing the risk factors for HSV keratitis can reduce its occurrence
Arthur Cummings
Published: Saturday, February 21, 2015
Almost everyone is at some risk for herpes simplex virus (HSV) keratitis, although there are several risk factors that need to be kept in mind and prophylaxis in those cases can reduce the risk of recurrence by around 50 per cent , said Marc Labetoulle MD, Paris, France, at the ESCRS/EuCornea Cornea Day during the 19th ESCRS Meeting in Istanbul. Dr Labetoulle noted that some studies suggest that antibodies to the virus are present in up to 90 percent of people by the age of 50 years. The lifetime risk of herpes simplex keratitis is 0.23 per cent by 30 years and 0.49 per cent by 50 years. The disease occurs in about 150/100,000 of the general population. In around a third of cases there are triggering factors involved. They include stress and fatigue, infectious diseases, ultraviolet radiation and ocular surgery.HSV keratitis accounts for about 10 percent of graft indications and for about a third of graft failures, Dr Labetoulle said. Therefore, prevention of herpes simplex keratitis is mandatory in eyes of patients with a history of HSV undergoing keratoplasty procedures. Acyclovir 400 mg twice daily reduces the recurrence rate by half.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...